Moreover, Zang et al. demonstrated that, by interfering with Notch1 and Akt/β-catenin signaling in GC, luteolin reversed the EMT process and, consequently, inhibited tumor progression and invasion, both in vitro and in vivo [35]. Here, AKT1 is linked to gastric cancer.